Neil Blodker
Vice President of Investor Relations
Replay available
Kestra Medical Technologies, Ltd. (KMTS) Q3 2026 Earnings Call
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) Q3 2026 earnings conference call, held 2026-03-17. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Brian Webster
President and Chief Executive Officer
Vasim Mebboub
Chief Financial Officer
Travis Steed
Analyst, Bank of America Securities
Matthew O'Brien
Analyst, Piper Sandler
Nathan Trey
Analyst, Wells Fargo
Michael Polark
Analyst, Wolf Research
Rick Wise
Analyst, CFO
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Kestra Medical Technologies, Ltd..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.678 Good afternoon. Welcome to Cash for Medical Technologies earnings conference call. 00:00:04.678 -- 00:00:08.203 This conference call is being recorded for replay purposes. 00:00:08.203 -- 00:00:12.649 We will be facilitating a question and answer session following prepared remarks from 00:00:12.649 -- 00:00:16.896 management. At this time, all participants are in listen-only mode. 00:00:16.896 -- 00:00:21.422 I would like to turn the call over to Neil Blodker, Vice President of Investor Relations, 00:00:21.422 -- 00:00:24.123 for introductory comments. 00:00:24.126 -- 00:00:29.287 Thank you, Victor. Good afternoon. Thank you for joining Kestra's Third Quarter Fiscal 00:00:29.287 -- 00:00:34.294 2026 Earnings Call. With me today are Brian Webster, President and 00:00:34.294 -- 00:00:39.701 Chief Executive Officer, and Vasim Mebboub, Chief Financial Officer. 00:00:39.701 -- 00:00:44.367 This call includes forward-looking statements within the meanings of the Private Securities 00:00:44.367 -- 00:00:47.171 Litigational Reform Act of 1995. 00:00:47.171 -- 00:00:51.597 Statements made on this call that do not relate to matters of historical fact should 00:00:51.597 -- 00:00:55.950 be considered forward-looking statements. These statements are based on Kestra's current 00:00:55.950 -- 00:01:01.397 expectations, forecasts, and assumptions, which are subject to inherent uncertainties, 00:01:01.397 -- 00:01:04.441 risks, and assumptions that are difficult to predict. 00:01:04.441 -- 00:01:09.167 Actual outcomes and results could differ materially from any results, performance, or 00:01:09.167 -- 00:01:14.695 achievements expressed or implied by the forward-looking statements due to various factors. 00:01:14.695 -- 00:01:20.182 Please review...